← Back to Bills
S 4667118th CongressFailed / ExpiredSenate

Risky Research Review Act

Policy Area: Health
View on Congress.gov
Origin Chamber
Senate
Last Updated
May 30, 2026
Latest Action Date
Dec 5, 2024

Latest Action

Placed on Senate Legislative Calendar under General Orders. Calendar No. 667.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Risky Research Review Act (S.4667) was a Senate bill introduced in the 118th Congress aimed at addressing issues related to health research that may involve elevated risks. Although the official summary and full text are not available, the bill's title and policy area suggest a focus on reviewing or regulating health-related research activities considered risky. The bill was placed on the Senate Legislative Calendar but ultimately failed or expired without further action.

Bottom Line

S.4667 sought to establish a review process for health research involving risks but did not advance beyond being scheduled on the Senate calendar and expired without passage.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the Senate during the 118th Congress and categorized under the health policy area.
  • No official summary or full text is publicly available, limiting detailed analysis of provisions.
  • The latest procedural action was placement on the Senate Legislative Calendar under General Orders, Calendar No. 667, on December 5, 2024.
  • The bill status is recorded as failed or expired, indicating it did not become law.
Who Benefits?

['Researchers and institutions conducting health-related research that may involve elevated risks', 'Government agencies responsible for oversight of health research', 'Potentially, patients and the general public through enhanced review of risky health research']

Potential Concerns

['Lack of publicly available bill text and summary limits understanding of specific implementation mechanisms and oversight provisions', 'Unclear funding sources or budgetary impact due to missing text', "Potential challenges in defining and regulating 'risky' research without detailed criteria", 'Uncertainty about enforcement authorities and responsibilities']

Political Context

The bill was introduced in the Senate during the 118th Congress and assigned to the health policy area. It was placed on the Senate Legislative Calendar but did not progress to a vote or enactment, resulting in its expiration. No further legislative actions or amendments are recorded.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increased administrative burden on research institutions if a review process for risky research were established', 'Possible delays in health research projects pending review outcomes', 'Enhanced public trust in health research oversight if review mechanisms were implemented']

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public understanding of the Risky Research Review Act. This lack of information poses challenges for oversight and informed debate. Future legislative efforts would benefit from ensuring full accessibility of bill texts and summaries to facilitate comprehensive analysis and stakeholder engagement.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready